We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
My 66-year-old husband recently received a diagnosis of heart failure with preserved ejection fraction. He is 5 feet, 7 ...
Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
My 66-year-old husband recently received a diagnosis of heart failure with preserved ejection fraction. He is 5 feet, 7 inches tall, and weighs 270 pounds. He is treating his fluid retention with 100 ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...
During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...
Depression risk for patients receiving GLP-1 RA was slightly higher than those receiving SGLT-2i and lower than those receiving DPP-4i.
Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...
With increasing demand and higher costs, ensuring appropriate patient access is more critical than ever and 2025 will likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results